vs
STANDARD BIOTOOLS INC.（LAB）与NELNET INC（NNI）财务数据对比。点击上方公司名可切换其他公司
NELNET INC的季度营收约是STANDARD BIOTOOLS INC.的1.7倍（$33.5M vs $19.6M），NELNET INC净利率更高（172.3% vs -177.4%，领先349.7%），NELNET INC同比增速更快（79.6% vs -11.5%），NELNET INC自由现金流更多（$396.7M vs $-23.1M），过去两年NELNET INC的营收复合增速更高（62.0% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
Nelnet（耐尔奈特）是总部位于美国内布拉斯加州林肯市的综合性企业集团，核心业务涵盖金融服务领域，主营学生贷款、消费贷款的发放与服务，同时设有投资板块与互联网银行，还持有有线电视及网络服务商Allo Fiber 26%的股权。
LAB vs NNI — 直观对比
营收规模更大
NNI
是对方的1.7倍
$19.6M
营收增速更快
NNI
高出91.1%
-11.5%
净利率更高
NNI
高出349.7%
-177.4%
自由现金流更多
NNI
多$419.8M
$-23.1M
两年增速更快
NNI
近两年复合增速
-12.2%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $33.5M |
| 净利润 | $-34.7M | $57.8M |
| 毛利率 | 48.5% | 50.5% |
| 营业利润率 | -168.5% | — |
| 净利率 | -177.4% | 172.3% |
| 营收同比 | -11.5% | 79.6% |
| 净利润同比 | -28.8% | -8.5% |
| 每股收益（稀释后） | $-0.09 | $1.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LABNNI
| Q4 25 | — | $33.5M | ||
| Q3 25 | $19.6M | $23.2M | ||
| Q2 25 | $21.8M | $26.1M | ||
| Q1 25 | $40.8M | $24.7M | ||
| Q4 24 | — | $18.7M | ||
| Q3 24 | $22.1M | $16.6M | ||
| Q2 24 | $22.5M | $14.9M | ||
| Q1 24 | $45.5M | $12.8M |
净利润LABNNI
| Q4 25 | — | $57.8M | ||
| Q3 25 | $-34.7M | $106.7M | ||
| Q2 25 | $-33.5M | $181.5M | ||
| Q1 25 | $-26.0M | $82.6M | ||
| Q4 24 | — | $63.2M | ||
| Q3 24 | $-26.9M | $2.4M | ||
| Q2 24 | $-45.7M | $45.1M | ||
| Q1 24 | $-32.2M | $73.4M |
毛利率LABNNI
| Q4 25 | — | 50.5% | ||
| Q3 25 | 48.5% | 29.6% | ||
| Q2 25 | 48.8% | 29.8% | ||
| Q1 25 | 48.4% | 30.5% | ||
| Q4 24 | — | 13.7% | ||
| Q3 24 | 54.9% | 0.1% | ||
| Q2 24 | 46.1% | 27.3% | ||
| Q1 24 | 53.1% | 15.3% |
营业利润率LABNNI
| Q4 25 | — | — | ||
| Q3 25 | -168.5% | — | ||
| Q2 25 | -118.1% | — | ||
| Q1 25 | -80.8% | — | ||
| Q4 24 | — | 97.7% | ||
| Q3 24 | -120.9% | -13.4% | ||
| Q2 24 | -134.5% | 88.0% | ||
| Q1 24 | -132.2% | — |
净利率LABNNI
| Q4 25 | — | 172.3% | ||
| Q3 25 | -177.4% | 460.5% | ||
| Q2 25 | -153.7% | 694.9% | ||
| Q1 25 | -63.8% | 334.4% | ||
| Q4 24 | — | 338.2% | ||
| Q3 24 | -122.0% | 14.4% | ||
| Q2 24 | -203.3% | 303.6% | ||
| Q1 24 | -70.6% | 574.4% |
每股收益（稀释后）LABNNI
| Q4 25 | — | $1.62 | ||
| Q3 25 | $-0.09 | $2.94 | ||
| Q2 25 | $-0.09 | $4.97 | ||
| Q1 25 | $-0.07 | $2.26 | ||
| Q4 24 | — | $1.74 | ||
| Q3 24 | $-0.07 | $0.07 | ||
| Q2 24 | $-0.12 | $1.23 | ||
| Q1 24 | $-0.27 | $1.98 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $296.0M |
| 总债务越低越好 | — | $7.8B |
| 股东权益账面价值 | $399.7M | $3.7B |
| 总资产 | $539.6M | $14.1B |
| 负债/权益比越低杠杆越低 | — | 2.11× |
8季度趋势，按日历期对齐
现金及短期投资LABNNI
| Q4 25 | — | $296.0M | ||
| Q3 25 | $129.4M | $216.4M | ||
| Q2 25 | $158.6M | $225.8M | ||
| Q1 25 | $150.9M | $220.5M | ||
| Q4 24 | — | $194.5M | ||
| Q3 24 | $210.6M | $219.7M | ||
| Q2 24 | $269.8M | $145.5M | ||
| Q1 24 | $287.1M | $179.7M |
总债务LABNNI
| Q4 25 | — | $7.8B | ||
| Q3 25 | — | $7.8B | ||
| Q2 25 | — | $7.9B | ||
| Q1 25 | — | $8.7B | ||
| Q4 24 | — | $8.3B | ||
| Q3 24 | $55.2M | $8.9B | ||
| Q2 24 | $55.1M | $9.6B | ||
| Q1 24 | $55.0M | $10.6B |
股东权益LABNNI
| Q4 25 | — | $3.7B | ||
| Q3 25 | $399.7M | $3.7B | ||
| Q2 25 | $424.5M | $3.6B | ||
| Q1 25 | $454.6M | $3.4B | ||
| Q4 24 | — | $3.3B | ||
| Q3 24 | $489.3M | $3.3B | ||
| Q2 24 | $510.3M | $3.3B | ||
| Q1 24 | $577.3M | $3.3B |
总资产LABNNI
| Q4 25 | — | $14.1B | ||
| Q3 25 | $539.6M | $13.9B | ||
| Q2 25 | $557.0M | $13.7B | ||
| Q1 25 | $579.6M | $14.2B | ||
| Q4 24 | — | $13.8B | ||
| Q3 24 | $681.5M | $14.1B | ||
| Q2 24 | $708.7M | $14.5B | ||
| Q1 24 | $777.7M | $15.4B |
负债/权益比LABNNI
| Q4 25 | — | 2.11× | ||
| Q3 25 | — | 2.14× | ||
| Q2 25 | — | 2.21× | ||
| Q1 25 | — | 2.53× | ||
| Q4 24 | — | 2.48× | ||
| Q3 24 | 0.11× | 2.72× | ||
| Q2 24 | 0.11× | 2.90× | ||
| Q1 24 | 0.10× | 3.20× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $423.0M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $396.7M |
| 自由现金流率自由现金流/营收 | -118.1% | 1183.0% |
| 资本支出强度资本支出/营收 | 4.5% | 78.2% |
| 现金转化率经营现金流/净利润 | — | 7.32× |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $663.4M |
8季度趋势，按日历期对齐
经营现金流LABNNI
| Q4 25 | — | $423.0M | ||
| Q3 25 | $-22.2M | $112.4M | ||
| Q2 25 | $-20.7M | $81.8M | ||
| Q1 25 | $-30.3M | $91.2M | ||
| Q4 24 | — | $662.9M | ||
| Q3 24 | $-27.9M | $137.0M | ||
| Q2 24 | $-39.0M | $133.8M | ||
| Q1 24 | $-62.5M | $211.6M |
自由现金流LABNNI
| Q4 25 | — | $396.7M | ||
| Q3 25 | $-23.1M | $100.8M | ||
| Q2 25 | $-22.6M | $78.1M | ||
| Q1 25 | $-35.3M | $87.8M | ||
| Q4 24 | — | $642.0M | ||
| Q3 24 | $-30.1M | $132.6M | ||
| Q2 24 | $-41.0M | $123.1M | ||
| Q1 24 | $-63.3M | $188.3M |
自由现金流率LABNNI
| Q4 25 | — | 1183.0% | ||
| Q3 25 | -118.1% | 435.0% | ||
| Q2 25 | -103.6% | 299.0% | ||
| Q1 25 | -86.6% | 355.6% | ||
| Q4 24 | — | 3438.0% | ||
| Q3 24 | -136.4% | 797.9% | ||
| Q2 24 | -182.2% | 829.2% | ||
| Q1 24 | -138.9% | 1473.7% |
资本支出强度LABNNI
| Q4 25 | — | 78.2% | ||
| Q3 25 | 4.5% | 50.4% | ||
| Q2 25 | 8.7% | 14.2% | ||
| Q1 25 | 12.4% | 13.7% | ||
| Q4 24 | — | 111.9% | ||
| Q3 24 | 10.2% | 26.7% | ||
| Q2 24 | 8.6% | 71.5% | ||
| Q1 24 | 1.7% | 181.7% |
现金转化率LABNNI
| Q4 25 | — | 7.32× | ||
| Q3 25 | — | 1.05× | ||
| Q2 25 | — | 0.45× | ||
| Q1 25 | — | 1.10× | ||
| Q4 24 | — | 10.50× | ||
| Q3 24 | — | 57.39× | ||
| Q2 24 | — | 2.97× | ||
| Q1 24 | — | 2.88× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
NNI
暂无分部数据
